Indonesia leaders launch country’s first homegrown COVID-19 vaccine
Indonesia’s leader launched the country’s first home-grown COVID-19 shot Thursday to help reduce the world’s fourth most populous nation’s dependency […]
vaccine
Hyderabad bags Rs 700 crore animal vaccine facility
Indian Immunologicals Ltd (IIL) said the facility, which will hire 750 employees, would help meet the vaccine security of the
Scientists test new malaria vaccine with box full of mosquitoes: ‘Whole forearm swelled’
NEWYou can now listen to Fox News articles! Scientists are trying to find a new malaria vaccine by sticking people’s
World Rabies Day 2022: know rabies history symptoms treatment vaccine precaution sscmp | World Rabies Day 2022: सिर्फ कुत्तों से ही नहीं इन जानवरों के काटने से भी होता है रेबीज, जानिए शुरुआती लक्षण
World Rabies Day 2022: आपने हाल के पिछले कुछ दिनों में कुत्तों के काटने के कई सारे मामलों के बारे में
Canada PM Trudeau lifts vaccine border mandate center of Ottawa ‘Freedom Convoy’ protests, police crackdown
NEWYou can now listen to Fox News articles! Canadian Prime Minister Justin Trudeau reportedly signed off on dropping the border
New York judge rules COVID vaccine mandate for NYPD union members invalid
NEWYou can now listen to Fox News articles! A New York judge ruled Friday that the city’s mandate requiring members
Flu vaccine may reduce the risk of stroke new research reveals sscmp | Stroke: फ्लू के टीके से कम हो सकता है स्ट्रोक का खतरा, नए रिसर्च में हुआ खुलासा
Flu vaccine reduce risk of stroke: स्ट्रोक के मरीजों के लिए एक अच्छी खबर है. खबरों के मुताबिक फ्लू का टीका
Malaria Vaccine R21 Oxford booster dose will give 80 percent protection know when it will be available sscmp | न्यू मलेरिया वैक्सीन R21: ऑक्सफोर्ड का बूस्टर डोज देगा 80% सुरक्षा, जानें कब से भारतीय बाजारों में मिलेगा टीका
Malaria Vaccine: मलेरिया एक जानलेवा बीमारी है और हर साल लाखों लोग इस मच्छर जनित बीमारी का शिकार हो जाते हैं.
Drug regulator’s nod sought for third phase study of intranasal Covid vaccine in 5-18 age group-
By PTI NEW DELHI: Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of
India’s first intranasal Covid vaccine gets regulator’s nod-
By Express News Service NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech’s intranasal Covid